首页> 外国专利> POLYPEPTIDES CONTAINING SEQUENCES FROM RESIDUES 61 TO 82 OR 104 TO 129 OF HUMAN IL-4 OR SUBSEQUENCES THEREOF; ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS

POLYPEPTIDES CONTAINING SEQUENCES FROM RESIDUES 61 TO 82 OR 104 TO 129 OF HUMAN IL-4 OR SUBSEQUENCES THEREOF; ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS

机译:含有人IL-4残基61至82或104至129的序列的多肽或其序列;抗体和药物成分

摘要

Two kinds of antibody antagonists of the binding of human IL-4 to cellular receptors are provided by this invention. Some of the antagonists bind to specific regions of IL-4 which are believed to be involved in interactions between IL-4 and its receptors. Because of this specific binding by the antibodies to the IL-4, the binding of the IL-4 to the receptors is substantially inhibited. The other antibody antagonists of the invention are anti-idiotypic antibodies which, while lacking IL-4 activity, appear to mimic IL-4 and to compete directly with it for binding to the cellular receptors. Polypeptides used to make the antibody antagonists are also provided, together with methods for using the antagonists to inhibit the binding of IL-4 to its cellular receptors.
机译:本发明提供了两种人IL-4与细胞受体结合的抗体拮抗剂。一些拮抗剂结合至IL-4的特定区域,据信它们与IL-4及其受体之间的相互作用有关。由于抗体与IL-4的这种特异性结合,因此IL-4与受体的结合被显着抑制。本发明的其他抗体拮抗剂是抗独特型抗体,其缺乏IL-4活性,但似乎模仿IL-4并与其直接竞争结合细胞受体。还提供了用于制备抗体拮抗剂的多肽,以及使用拮抗剂抑制IL-4与其细胞受体结合的方法。

著录项

  • 公开/公告号NZ236511A

    专利类型

  • 公开/公告日1993-02-25

    原文格式PDF

  • 申请/专利权人 SCHERING CORP;

    申请/专利号NZ19900236511

  • 申请日1990-12-18

  • 分类号C07K7/06;C07K7/08;C07K7/10;C07K15/06;C12P21/08;A61K39/395;

  • 国家 NZ

  • 入库时间 2022-08-22 05:10:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号